Back
Amedisys 10K Form
Buy
61
AMED
Amedisys
Last Price:
94.45
Seasonality Move:
11.39%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-25 | 10Q | AMED/Amedisys Quarterly |
| 2023-10-25 | 10Q | AMED/Amedisys Quarterly |
| 2023-07-27 | 10Q | AMED/Amedisys Quarterly |
| 2023-05-04 | 10Q | AMED/Amedisys Quarterly |
| 2022-10-27 | 10Q | AMED/Amedisys Quarterly |
| 2022-07-28 | 10Q | AMED/Amedisys Quarterly |
Receive AMED News And Ratings
See the #1 stock for the next 7 days that we like better than AMED
AMED Financial Statistics
Sales & Book Value
| Annual Sales: | $2.24B |
|---|---|
| Cash Flow: | $-9.43M |
| Price / Cash Flow: | 34.13 |
| Annual Sales: | $33.30 |
| Price / Book: | 2.84 |
Profitability
| EPS (TTM): | -0.64000 |
|---|---|
| Net Income (TTM): | $-20.59M |
| Gross Margin: | $990.87M |
| Return on Equity: | -1.86% |
| Return on Assets: | -1.02% |
Amedisys Earnings Forecast
Key Amedisys Financial Ratios
- The Gross Profit Margin over the past 31 years for AMED is 44.31%.
- The Selling, General & Administrative Expenses for AMED have been equal to 34.88% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is -320.86% of Operating Income.
- The Net Earning history of AMED is -0.44% of Total Revenues.
- Per Share Earnings over the last 31 years have been positive in 17 years.
Amedisys Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | AMED |
| CUSIP: | 023436 |
| Website: | amedisys.com |
Debt
| Debt-to-Equity Ratio: | 0.36 |
|---|---|
| Current Ratio: | 1.09 |
| Quick Ratio: | 0.96 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 18.8 |